Relay Therapeutics (RLAY) PT Raised to $18 at Oppenheimer

April 27, 2026 4:30 PM

Oppenheimer analyst Matt Biegler raised the price target on Relay Therapeutics (NASDAQ: RLAY) to $18.00 (from $14.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found